The progress of angiogenic factors in the development of leukemias-Reference-Cited by-同舟云学术

The progress of angiogenic factors in the development of leukemias

Published:2016 Issue:1 Volume:5 Page:6-16
ISSN:2186-361X
Container-title:Intractable & Rare Diseases Research
language:en
Short-container-title:IRDR

Author:

Han Yang¹²,Wang Xidi³,Wang Bingping⁴,Jiang Guosheng¹

Affiliation:

1. Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Institute of Basic Medicine, Shandong Academy of Medical Sciences

2. School of Medicine and Life Sciences, Ji'nan University

3. Laboratory Department, People's Hospital of Zhangqiu City

4. Department of Hematology, Shengli Oilfield Central Hospital

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/irdr/5/1/5_2015.01048/_pdf

Reference110 articles.

1. 1. Medinger M, Passweg J. Angiogenesis in myeloproliferative neoplasms, new markers and future directions. Memo. 2014; 7:206-210.

2. 2. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1997; 150:815-821.

3. 3. Jain RK. Antiangiogenesis strategies revisited: From starving tumors to alleviating hypoxia. Cancer Cell. 2014; 26:605-622.

4. 4. Piechnik A, Dmoszynska A, Omiotek M, Mlak R, Kowal M, Stilgenbauer S, Bullinger L, Giannopoulos K. The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients. Int J Cancer. 2013; 133:1489-1496.

5. 5. Aguirre Palma LM, Gehrke I, Kreuzer KA. Angiogenic factors in chronic lymphocytic leukaemia (CLL): Where do we stand? Crit Rev Oncol Hematol. 2015; 93:225-236.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation mediated angiogenesis in chronic lymphocytic leukemia;Annals of Hematology;2024-05-07

2. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways;Cell Communication and Signaling;2023-09-21

3. A comprehensive insight into the role of molecular pathways affected by the Angiopoietin and Tie system involved in hematological malignancies' pathogenesis;Pathology - Research and Practice;2023-08

4. An overview of the molecular and clinical significance of the angiopoietin system in leukemia;Journal of Receptors and Signal Transduction;2023-03-04

5. Targeting PI3K/Akt signal transduction for cancer therapy;Signal Transduction and Targeted Therapy;2021-12